CompletedPHASE2, PHASE3NCT06265051

Tirofiban After Successful MT Recanalization in AIS

Studying Androgen insensitivity syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xiang Luo
Principal Investigator
Xiang Luo
Tongji Hospital
Intervention
Tirofiban(drug)
Enrollment
1380 target
Eligibility
18 years · All sexes
Timeline
20242025

Study locations (1)

Collaborators

Fujian Medical University Union Hospital · Jingzhou Hospital Affiliated to Yangtze University · Xiangyang No 1 People's Hospital Affiliated to Hubei University of Medicine · Puren Hospital Affiliated to Wuhan University of Science and Technology · Zhongnan Hospital · First Affiliated Hospital of Fujian Medical University · Wuhan Central Hospital · Xianning Central Hospital · Shanxi Provincial People's Hospital · The Third People's Hospital of Hubei Province · Jingmen Central Hospital · Hubei University of Medicine · Wuhan No.1 Hospital · Nanyang Central Hospital · Yichang Central People's Hospital of China Three Gorges University · The Central Hospital of Huanggang · Zoucheng City People's Hospital · Qujing Central Hospital of Yunnan Province · Taihe Hospital, Affiliated Hospital of Hubei Province of Medicine · Second Affiliated Hospital of Soochow University · The First Affiliated Hospital of Nanchang University · Central Hospital of Xiaogan · The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture · Huangshi Central Hospital · Zigong No.1 Peoples Hospital · Xiangyang Hospital of Traditional Chinese Medicine · The First People's Hospital of Jingzhou City · First People's Hospital of Xianyang · Jiujiang No.1 People's Hospital · Zhongxiang Hospital of Traditional Chinese Medicine · Jiangxi Provincial People's Hopital · The Lichuan ethnic Hospital of Traditional Chinese Medicine · Xiangyang Central Hospital People's Hospital of Huangpi District · Quanzhou First Hospital · Minda Hospital of Hubei Minzu University · The Cerebrovascular Hospital of Hubei Province · The First People's Hospital of Changde City · Longyan First Affiliated Hospital of Fujian Medical University · Xiangzhou People's Hospital · Jingmen People's Hospital · The First People's Hospital of TianMen in Hubei Province · Hanyang Hospital, Wuhan University of Science & Technology · Tongcheng People's Hospital · Gaoyou People's Hospital · Zaoyang First People's Hospital · CR & WISCO General Hospital · Wuhan Hankou Hospital · Lu'an People's Hospital of Anhui Hospital · Yingtan People's Hospital · Shiyan Renmin Hospital · Dali Bai Autonomous Prefecture People's Hospital · Three Gorges Hospital of Chongqing University · The Second People's Hospital of Jingzhou City · General Hospital of the Yangtze River Shipping · The Affiliated Hospital Of Southwest Medical University · Fujian Provincial Hospital · Zhongxiang People's Hospital · LiuZhou People's Hospital · The Fifth Hospital of Wuhan · Xiaogan First People's Hospital · Loudi Central Hospital · Ezhou Central Hospital · Second Xiangya Hospital of Central South University · Qingdao Central Hospital · Taizhou First People's Hospital · Renmin Hospital of Wuhan University · Hubei Provincial Hospital of Integrated Chinese & Western Medicine · The First Affiliated Hospital of Botou Medical College · Xianfeng People's Hospital · Wuhan Third Hospital · The Fourth Hospital of Wuhan · Chengdu Fifth People's Hospital · Xingyi People's Hospital · Affiliated Hospital of Shandong University of Traditional Chinese Medicine · Shenzhen Hospital of Southern Medical University · The Third People's Hospital of Jingzhou City · The First People's Hospital of Jiangxia District · Xihua People's Hospital · Shanghai East Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06265051 on ClinicalTrials.gov

Other trials for Androgen insensitivity syndrome

Additional recruiting or active studies for the same condition.

See all trials for Androgen insensitivity syndrome

← Back to all trials